Abstract:Food protein-derived peptides have been recognised as an important category of functional food materials, which exert various bioactivities and possible health-promoting impacts in human beyond their traditional nutritional values (Hern andez-Ledesma & Hsieh, 2017; Aguilar et al., 2019). Bioactive peptides could be produced by food processing processes such as fermentation, etc., from longer polypeptides or proteins. A growing body of scientific evidence has demonstrated that peptides bearing characteristic sequences can prevent various lifestyle-related diseases such as diabetic, hypertension and atherosclerosis. In addition to bioactivities, current peptide researches focus on physiological stability in the gastrointestinal tract as well as intestinal absorption to understand the bioaccessibility and bioavailability of bioactive peptides (Matsui, 2018). This special issue summarises current understandings on bioaccessibility and bioavailability of food protein-derived bioactive peptides, which also include a review on clinical aspects of bioactive peptides, as well as future challenges and ongoing research needs in the field of peptide science. Written by world renowned leading scientists, it is hoped that the knowledge and insights gained from this special issue will lead to further development in the rapidly growing field of bioactive peptides from food proteins. Epidemiological studies have revealed that consumption of milk and fermented dairy products is inversely associated with elevated blood pressure and with many of the risk factors of the metabolic syndrome and combats against hypertension and vascular dysfunction. An overview of the potential blood pressure lowering components present in dairy products with a special focus on casein-derived tripeptides was described. Dairy proteinderived bioactive peptides (DBPs) have potential benefits for human health. However, their transport mechanisms and bioavailability from intestinal lumen to bloodstream are not well understood. Understanding of their transport mechanisms across the intestinal membrane (peptide transporter 1, paracellular route, transcytosis and passive transcellular diffusion) and the bioavailability of DBPs in animal and human studies were highlighted. Current research on in vitro and in vivo absorption of these compounds and factors that play a key role in this process provides better understanding of the in vitro and in vivo bioavailability and bioaccessibility of peptides. Peptides display diverse structural features because of their varied amino acid compositions. The structural diversity often imparts them complex physiological functions or possible health-beneficial effects. Some small peptides (di-/tripeptides) exert preventive effects against conditions such as hypertension, hypercholesterolaemia and atherosclerosis. Despite their health benefits, a limited understanding of peptide absorption may hinder their extensive application. Therefore, in vitro and in vivo findings on the intestinal absorption of small peptides and potential factors affecting their absorption were emphasised. Bioactive peptides can be protected from the gastrointestinal environment by microencapsulation. Microcapsules obtained by spray drying using maltodextrin/gun arabic in optimal formula preserved the a-glucosidase, a-amylase and dipeptidyl peptidase-IV inhibitory activity of P. lunatus peptides after in vitro gastrointestinal digestion. Lupine (Lupinus angustifolius L.) protein (in wholemeal and protein isolates) was biodegraded using Pediococcus acidilactici in submerged and solid-state fermentation conditions. Biodegradation improved the antioxidant properties, modulated the antimicrobial properties and led to higher in vitro and in vivo digestibility and functionality of the lupine in treated rats. Diabetes mellitus is a complex disorder caused by insufficient insulin production or insulin resistance. It was to update the state-of-the-art regarding the origin, structural characteristics, action and potential mechanisms of bioactive peptides on the key enzymes and proteins, i.e., a-amylase, a-glucosidase. Epidemiological studies have shown that soy consumption is associated with lower incidence of various diseases, including cancer. Over the past decades, soy proteins and derived peptides have been considered as potential preventive agent against the initiation, promotion and progression of cancer. Specifically emphasising This Editorial should have been published in Special Issue 54:6 (‘Bioaccessibility and bio-availability of food derived bioactive peptides’) but, due to a production error, was published in issue 54:7 instead. The publisher apologizes for this error and the inconvenience caused. International Journal of Food Science and Technology 2019, 54, 2319–2320

Health benefits of bioactive peptides produced from muscle proteins: Antioxidant, anti-cancer, and anti-diabetic activities

Bioactive Peptides of Plant Origin: Distribution, Functionality, and Evidence of Benefits in Food and Health

Production and Functionality of Food-derived bioactive peptides: A review.

Bioactivities, Applications, Safety, and Health Benefits of Bioactive Peptides From Food and By-Products: A Review

Antioxidative, Glucose Management, and Muscle Protein Synthesis Properties of Fish Protein Hydrolysates and Peptides

Entrance and exit dose regions for a Clinac-2100C.

Current understanding of bioaccessibility and bioavailability of food‐derived bioactive peptides

Production Technology and Functionality of Bioactive Peptides

Identification, protein antiglycation, antioxidant, antiproliferative, and molecular docking of novel bioactive peptides produced from hydrolysis of Lens culinaris

Mechanisms of glioma-associated neovascularization.

Physiological and Clinical Aspects of Bioactive Peptides from Marine Animals

Recent Advancements in Novel Bioactive Peptides and Protein Hydrolysates Isolated from Different Medicinal Plants Along with Their Applications in Food and Pharmaceutical Industries

A new algorithm for distance cartogram construction

A review on bioactive peptides derived from meat and by-products: Extraction methods, biological activities, applications and limitations

Food-Derived Bioactive Peptides in Human Health: Challenges and Opportunities

Molecular Targets and Mechanisms of Bioactive Peptides Against Metabolic Syndromes

Food protein-derived bioactive peptides in management of type 2 diabetes

Protein hydrolysates in animal nutrition: Industrial production, bioactive peptides, and functional significance

Bioactive Peptides: Synthesis, Sources, Applications, and Proposed Mechanisms of Action

Identification of dipeptidyl peptidase-IV inhibitory peptides from yak bone collagen by in silico and in vitro analysis

Current Trends of Bioactive Peptides—New Sources and Therapeutic Effect